TGM3 and acute lymphoblastic leukemia: The hazard ratios for TGM3 were significant for KIPAN, KIRC, LAML, SKCM, uterine carcinosarcoma (UCS), ALL and PAAD, among which TGM3 had the highest risk effect in UCS and was a protective factor in PAAD (Figure 2A).